Nicolo Riggi is a Senior Principal Scientist and Director at Genentech, a position held since 2022. Previously, they were an Assistant Professor at CHUV | Lausanne University Hospital and MGH Cancer Center of Harvard and MIT from 2015 to 2022, following a role as a Postdoctoral Researcher and Clinical Fellow at MGH from 2011 to 2015. Nicolo completed a Clinical Pathology Residency at the University Hospital of Lausanne between 2008 and 2011 and holds a PhD in Cell/Cellular and Molecular Biology from the University of Lausanne, completed in 2008. Their medical education includes an MD from the University of Lausanne, obtained in 2001.
This person is not in any teams
This person is not in any offices